Key Takeaways Expansion into US and Asian markets, alongside robust order intake and backlog, is set to drive diversified and stable future revenue growth. Investment in high-margin aftermarket solutions, digitalization, and innovative R&D strengthens recurring revenues and maintains SKAN's leadership in advanced pharmaceutical manufacturing technologies.Read more
SKAN Group AG, together with its subsidiaries, provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally. It operates in two segments, Equipment and Solutions; and Services and Consumables. The company offers accessories, biological indicators, digital ventures, isolators, cleanroom, laminar flow, particle counter, personal protective equipment, safety workbench, transfer systems, and fume cupboard. It also provides digital solutions, lifecycle support, laboratory services, and SKAN labs. The company was formerly known as BV Holding AG and changed its name to SKAN Group AG in October 2021. SKAN Group AG was founded in 1968 and is headquartered in Allschwil, Switzerland.
